Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (341-350 of 605) with videos related to

Pageof 61
Sort By:
Genetic Testing and Molecular Biomarkers|November 17, 2011
Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to childrenMcKane E Sharff, Tiffani A DeMarco, Darren Mays, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
BRCA1/2 genetic testing in the community settingWendy Y Chen, Judy E Garber, Suzanne Higham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Fatigue in Parkinson's disease: a reviewJoseph H Friedman, Richard G Brown, Cynthia Comella, et al.
Journal of the National Cancer Institute|October 15, 2025
Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control studyAdela Rodriguez-Hernandez, Miki Horiguchi, Carolyn Horton, et al.
Genetic Testing|February 25, 2005
Accuracy of cancer family histories: comparison of two breast cancer syndromesKatherine A Schneider, Lisa M DiGianni, Andrea Farkas Patenaude, et al.
Cancer Genetics|March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survivalJoyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Journal of the National Cancer Institute|August 15, 1992
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individualsF P Li, J E Garber, S H Friend, et al.
Cancer|April 2, 2019
Prevalence of germline variants in inflammatory breast cancerHuma Q Rana, Rosalba Sacca, Christine Drogan, et al.
Annals of Surgical Oncology|January 23, 2024
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast LesionsAlison Laws, Saskia Leonard, Emma Hershey, et al.
Journal of Surgical Oncology|July 21, 2007
Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?Davendra Segara, Ian E Krop, Judy E Garber, et al.
Pageof 61

Showing results (341-350 of 605) with videos related to

Sort By:
Pageof 61
Genetic Testing and Molecular Biomarkers|November 17, 2011
Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to childrenMcKane E Sharff, Tiffani A DeMarco, Darren Mays, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
BRCA1/2 genetic testing in the community settingWendy Y Chen, Judy E Garber, Suzanne Higham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Fatigue in Parkinson's disease: a reviewJoseph H Friedman, Richard G Brown, Cynthia Comella, et al.
Journal of the National Cancer Institute|October 15, 2025
Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control studyAdela Rodriguez-Hernandez, Miki Horiguchi, Carolyn Horton, et al.
Genetic Testing|February 25, 2005
Accuracy of cancer family histories: comparison of two breast cancer syndromesKatherine A Schneider, Lisa M DiGianni, Andrea Farkas Patenaude, et al.
Cancer Genetics|March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survivalJoyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Journal of the National Cancer Institute|August 15, 1992
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individualsF P Li, J E Garber, S H Friend, et al.
Cancer|April 2, 2019
Prevalence of germline variants in inflammatory breast cancerHuma Q Rana, Rosalba Sacca, Christine Drogan, et al.
Annals of Surgical Oncology|January 23, 2024
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast LesionsAlison Laws, Saskia Leonard, Emma Hershey, et al.
Journal of Surgical Oncology|July 21, 2007
Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?Davendra Segara, Ian E Krop, Judy E Garber, et al.
Pageof 61